BridgeMD
New treatment option for Osteoarthritis, Knee
Official title Is Non Surgical CaRE Using Treat to Target Multimodal meDIcal Strategies aBLE to Delay or Avoid Total Knee Replacement?
ClinicalTrials.gov ID: NCT06643845
What this study is testing
- What it's testing
- Knee is the most common site of osteoarthritis. Treatment of knee osteoarthritis starts with a full course of medical therapy, followed by surgery to replace the knee with a prosthesis if this strategy fails, or in advanced cases.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Age 18-90 years old
- Femoro-tibial osteoarthritis Kellgren stage stage≥ 2 without laxity in extension;
- A proposal of total knee replacement by a surgeon;
- No corticosteroid joint injection within 3 months;
- Visual analogic score pain (VAS) \>40/100 but \ 40/100 at inclusion;
You likely can't join if
- Contraindication or no indication to surgery or medical care (severe infection for example)
- Inflammatory arthritis
- Lack of social insurance
- Symptomatic (VAS pain \>40) contralateral knee or hip osteoarthritis (with or without replacement)
- Pregnant or breastfeeding woman
- Patient under court protection, guardianship, curatorship
See the full eligibility criteria
- Age 18-90 years old
- Femoro-tibial osteoarthritis Kellgren stage stage≥ 2 without laxity in extension;
- A proposal of total knee replacement by a surgeon;
- No corticosteroid joint injection within 3 months;
- Visual analogic score pain (VAS) \>40/100 but \ 40/100 at inclusion;
- Wish to discuss medical care;
- Able to consent and having signed a consent form.
- Contraindication or no indication to surgery or medical care (severe infection for example)
- Inflammatory arthritis
- Lack of social insurance
- Symptomatic (VAS pain \>40) contralateral knee or hip osteoarthritis (with or without replacement)
- Pregnant or breastfeeding woman
- Patient under court protection, guardianship, curatorship
- Patient deprived of liberty
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, France
- Brest, France
- Caen, France
- La Roche-sur-Yon, France
- Le Mans, France
- Limoges, France
- Lomme, France
- Lyon, France
- Montpellier, France
- Morlaix, France
- Nantes, France
- Nice, France
- Paris, France
- Quimper, France
- Reims, France
- Saint-Etienne, France
- Strasbourg, France
- Tours, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, France; Brest, France; Caen, France; La Roche-sur-Yon, France; Le Mans, France; Limoges, France and 12 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.